OVERSEA CHINESE BANKING Corp Ltd Invests $32.40 Million in Agilent Technologies, Inc. $A

OVERSEA CHINESE BANKING Corp Ltd acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 243,882 shares of the medical research company’s stock, valued at approximately $32,395,000. Agilent Technologies comprises approximately 0.7% of OVERSEA CHINESE BANKING Corp Ltd’s investment portfolio, making the stock its 26th largest position.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Fiduciary Trust Co boosted its holdings in Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after purchasing an additional 77 shares during the last quarter. Sapient Capital LLC raised its stake in Agilent Technologies by 4.2% during the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after buying an additional 85 shares during the last quarter. Plan A Wealth LLC lifted its holdings in shares of Agilent Technologies by 3.2% during the 4th quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after buying an additional 92 shares during the period. UNIVEST FINANCIAL Corp lifted its holdings in shares of Agilent Technologies by 1.3% during the 2nd quarter. UNIVEST FINANCIAL Corp now owns 7,145 shares of the medical research company’s stock valued at $949,000 after buying an additional 93 shares during the period. Finally, IHT Wealth Management LLC boosted its stake in shares of Agilent Technologies by 4.9% in the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock worth $278,000 after buying an additional 96 shares during the last quarter.

Analyst Ratings Changes

Several analysts recently commented on A shares. Wells Fargo & Company cut their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. Piper Sandler began coverage on Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target for the company. Barclays upped their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Finally, Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They issued a “hold” rating and a $135.00 price objective on the stock. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Trading Up 0.7%

NYSE:A opened at $156.50 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The firm has a market capitalization of $44.20 billion, a price-to-earnings ratio of 31.43, a price-to-earnings-growth ratio of 2.75 and a beta of 1.25. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The business has a fifty day moving average price of $136.98 and a 200-day moving average price of $126.00.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The company had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period last year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 6.03 EPS for the current year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.